Bone Morphogenetic Protein: Function, Uses, and Risks

Bone morphogenetic proteins (BMPs) are a group of signaling proteins, also known as growth factors, found naturally within the body. These proteins play a significant role in guiding the development and repair of various tissues, particularly bone and cartilage. They act as “instructors,” signaling specific cells to differentiate and form these specialized structures. BMPs were initially discovered for their ability to induce bone and cartilage formation, highlighting their profound influence on skeletal biology.

The Natural Role of BMPs in the Body

Bone morphogenetic proteins are instrumental during embryonic development, orchestrating the formation of the entire skeleton. They guide the differentiation of various cell types that contribute to bones, teeth, and limbs, ensuring precise embryonic patterning. Specific BMPs, such as BMP4, play a role in regulating the formation of these structures from mesoderm. BMPs interact with specific receptors on cell surfaces, initiating a signaling cascade that is fundamental for the early formation of cartilage and bone, including the development of long bones and other skeletal elements.

In adults, BMPs continue to play a part in maintaining bone health through a continuous process called bone remodeling. This process involves a delicate balance between the absorption of old bone by osteoclasts and the formation of new bone by osteoblasts. BMPs contribute to this balance by mediating the communication between these two cell types, ensuring bone tissue remains strong and functional. Their presence within the bone matrix allows for their involvement in mediating this coupling process, which is constant throughout life.

When a bone fracture occurs, BMPs are released at the injury site, initiating the complex repair cascade. They recruit mesenchymal stem cells from the periosteum and bone marrow, which are then directed to differentiate into chondrocytes and osteoblasts. This differentiation leads to the formation of a soft callus, which gradually transforms into new bone, facilitating the healing process. BMPs are therefore foundational to the body’s natural ability to mend broken bones and regenerate tissue.

Clinical Applications in Medicine

Bone morphogenetic proteins have become a significant tool in various medical and dental procedures, primarily by promoting new bone growth and enhancing the body’s natural healing processes. In spinal fusion surgery, synthetic BMPs offer an alternative to traditional bone grafts, which often require harvesting bone from the patient’s hip and can lead to donor site pain. Recombinant human BMP-2, marketed as INFUSE Bone Graft, is approved for specific uses like one-level anterior lumbar interbody fusion, typically delivered with a tapered fusion cage. This approach aims to reduce the need for autogenous bone grafts, minimizing patient discomfort associated with harvesting bone from another part of the body.

Another product, recombinant human BMP-7, known as OP-1 Putty, is approved for revision posterolateral lumbar spinal fusion under a humanitarian device exemption. These proteins are typically applied by soaking them onto an absorbable collagen sponge or a type I collagen carrier, which is then placed at the surgical site. While their approved uses are specific, some surgeons also utilize BMPs “off-label” for other spinal fusions, though this practice is subject to ongoing review.

BMPs are also employed in orthopedic trauma surgery to address complex or non-union fractures, where bones fail to heal naturally. They are particularly used for long bone non-unions and severe open tibial fractures to stimulate healing. BMP-2 and BMP-7 are the primary types used in these scenarios, often combined with surgical stabilization and sometimes with traditional bone grafts.

The proteins recruit mesenchymal cells and guide their differentiation into bone-forming cells, aiding in bone matrix production and vascularization at the fracture site. Their application can accelerate healing and potentially reduce the need for additional surgical interventions.

In dental procedures, BMPs play a role in socket preservation after tooth extraction and in sinus augmentation procedures, such as sinus lifts, where they are instrumental in preparing the jaw for future implants. For socket preservation, BMPs can be incorporated into bone substitute materials placed in the empty socket to reduce bone resorption and encourage new bone formation. In sinus lifts, they promote bone growth in the maxillary sinus, creating a sufficient foundation for dental implant placement in patients with significant bone loss. These applications enhance bone regeneration, improving outcomes for implant dentistry.

Risks and Side Effects of Clinical Use

While bone morphogenetic proteins offer significant benefits, their clinical use carries potential risks and side effects that warrant careful consideration. A primary concern, particularly in cervical spine surgeries, is severe inflammation and swelling. This can lead to complications such as airway obstruction, difficulty swallowing, and impaired breathing. The Food and Drug Administration (FDA) issued a black box warning for BMP-2 due to these life-threatening risks.

Beyond swelling, other inflammatory responses like seroma and hematoma formation have been reported. Another complication is ectopic bone formation, where new bone grows in unintended areas, often due to the protein migrating or leaking outside the intended surgical site. This phenomenon has been observed in various spinal procedures, potentially causing pain or other issues.

Nerve-related issues can also arise following BMP application, including postoperative radiculitis, nerve root injury, and in lumbar spine surgeries, retrograde ejaculation. These complications suggest that BMPs can sometimes interfere with nerve function or create an environment that impacts surrounding neural structures. Additionally, osteolysis, which is the resorption of bone, and implant displacement or subsidence have been linked to BMP use in some cases.

The potential link between BMPs and cancer has been a subject of historical controversy and ongoing research. While BMPs and their receptors have been identified in various human tumors, studies offer conflicting findings regarding their role in malignancy. Some research indicates that BMP-2 might enhance tumor function, particularly in terms of invasiveness and metastatic potential, while other studies suggest an inhibitory or neutral effect, especially on cancer cell proliferation.

It is important to note that no definitive evidence has shown BMP-2 to cause cancer de novo (from scratch). However, the existing conflicting data, sometimes indicating a dose-dependent risk, underscores the need for continued long-term follow-up studies and further research to fully understand this complex relationship. Therefore, diligent monitoring and adherence to established guidelines are important to mitigate potential complications associated with their use.

Recombinant BMP Production

The bone morphogenetic proteins used in medical treatments are not directly extracted from human bone but are instead created through a process called recombinant DNA technology. This advanced genetic engineering technique allows for the consistent and large-scale production of these complex proteins. The process begins by identifying the specific human gene that contains the instructions for making a particular BMP, such as BMP-2 or BMP-7.

Once identified, this human BMP gene is inserted into specially chosen host cells. Chinese hamster ovary (CHO) cells are frequently selected for this purpose due to several advantages. These cells are particularly adept at performing complex post-translational modifications, like glycosylation, which are necessary for the proteins to function correctly and mimic their natural human counterparts. This makes the proteins produced by CHO cells highly suitable for therapeutic use.

These genetically modified CHO cells then act as miniature “factories,” diligently following the inserted genetic instructions to produce large quantities of the desired recombinant BMP protein. The cells are grown in controlled laboratory environments, often in large bioreactors, to maximize protein yield. After production, the BMP proteins are meticulously purified from the cell culture supernatant using multi-step chromatographic procedures, ensuring a high-quality product suitable for clinical application. This rigorous purification process is essential to remove impurities and ensure the safety and efficacy of the final therapeutic product.

What Is Eye Tracing and How Does It Work?

What Is Brain Labeling and How Does It Work?

The FokI Nuclease and Its Role in Genome Engineering